Picture of Tricida logo

TCDAQ Tricida News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Tricida Reports Q4 Loss Per Share $0.66

March 28 (Reuters) - Tricida Inc  TCDA.O :
    * TRICIDA ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2018
FINANCIAL
RESULTS
    * Q4 LOSS PER SHARE $0.66
    * INITIAL TOPLINE DATA ANALYSES OF TRCA-301E TRIAL,
PLACEBO-CONTROLLED, BLINDED, 40-WEEK EXTENSION TRIAL, REVEALED
POSITIVE RESULTS
    * AMENDMENT TO ITS EXISTING DEBT FACILITY WITH HERCULES
CAPITAL,
INC., INCREASING TOTAL AMOUNT AVAILABLE UNDER DEBT FACILITY TO
UP TO $200 MILLION
    * TRCA-301E TRIAL MET ITS PRIMARY AND ALL SECONDARY
ENDPOINTS
    * ESTIMATES A CASH EXPENDITURE OF $135 TO $145 MILLION IN
2019
    * AS OF DECEMBER 31, 2018, CASH, CASH EQUIVALENTS AND
INVESTMENTS
WERE $243.4 MILLION

Source text for Eikon:  ID:nBw2kYWZJa 
Further company coverage:  TCDA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Tricida

See all news